Get started

Checkpoint Therapeutics, Inc

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

CKPT chart

Key stats

Market capitalization
42.081MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.75USD

About Checkpoint Therapeutics, Inc

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
James F. Oliviero
Website
checkpointtx.com
Headquarters
Waltham
Employees
24
Founded
2014
ISIN
US1628282063

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.

Ideas

CKPT making bullish movesCKPT has been in an upward trend since March last year and has recently broken out of a long negative trend, completing a cup pattern on the daily chart. I would expect it to perform a handle over the next few sessions to confirm the pattern, then continue its upward trajectory. The daily RSI is a
Long
1
$CKPT Checkpoint $3.50 target Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on No
Long
1
CKPT: Ascending Triangle, ConfirmedAscending Triangle, confirmed Pros: R/R ratio high, above 6 Descending volume during formation Volume spike at break out PPS above 50Ma and 200MA 250RSI above 50 ATR ascending, more volatiliy RS above 0 and ascending 200MA ascending Price Target: PT = 4.00$ No resistance above
Long
1

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.45Fabulous
Learn more
OANDA
OANDA
Forex
4.52Great
Learn more
FOREX.com
FOREX.com
Forex
4.36Fabulous
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.35Fabulous
Learn more

See all brokers 

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more